Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
McKesson
Boehringer Ingelheim
AstraZeneca
Mallinckrodt

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021583

See Plans and Pricing

« Back to Dashboard

NDA 021583 describes DEPO-SUBQ PROVERA 104, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the DEPO-SUBQ PROVERA 104 profile page.

The generic ingredient in DEPO-SUBQ PROVERA 104 is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
Summary for 021583
Tradename:DEPO-SUBQ PROVERA 104
Applicant:Pharmacia And Upjohn
Ingredient:medroxyprogesterone acetate
Patents:1
Formulation / Manufacturing:see details
Pharmacology for NDA: 021583
Suppliers and Packaging for NDA: 021583
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEPO-SUBQ PROVERA 104 medroxyprogesterone acetate INJECTABLE;SUBCUTANEOUS 021583 NDA Pharmacia and Upjohn Company LLC 0009-4709 0009-4709-13 1 SYRINGE in 1 CARTON (0009-4709-13) > .65 mL in 1 SYRINGE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;SUBCUTANEOUSStrength104MG/0.65ML
Approval Date:Dec 17, 2004TE:RLD:Yes
Patent:  Start TrialPatent Expiration:May 15, 2020Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Colorcon
Medtronic
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.